← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 31, 2009Last known activity
May 1, 2016
Timeline
2000s
- Jan 1, 2008
Andalusian Initiative for Advanced Therapies— Founded
Drugs by trial phase (9 distinct, 16 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Amyotrophic Lateral Sclerosis
- Atherosclerosis
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cerebral Infarction
- Coronary Artery Disease
- Coronary Occlusion
- Fecal Incontinence
- Graft vs Host Disease
- Heart Diseases
- Heart Failure
- Ischemia
- Motor Neuron Disease
- Myocardial Ischemia
- Sclerosis
- Stroke
- Ventricular Dysfunction
- Viremia
Recent trials (17)
- NCT02687646CollaboratorPhase 1/Phase 2May 1, 2016
- NCT02687646Lead sponsorPhase 1/Phase 2May 1, 2016
- NCT02178657Lead sponsorPhase 2Apr 1, 2015
- NCT02290041Lead sponsorPhase 1/Phase 2Mar 1, 2015
- NCT02290886Lead sponsorPhase 1/Phase 2Jul 1, 2014
- NCT02033278Lead sponsorPhase 2/Phase 3Jan 1, 2014
- NCT02022514Lead sponsorPhase 2/Phase 3Nov 1, 2013
- NCT02292628Lead sponsorPhase 1/Phase 2Oct 1, 2013
- NCT01745783Lead sponsorPhase 1/Phase 2Jan 31, 2013
- NCT01751243Lead sponsorPhase 1Jan 31, 2013
- NCT02287974Lead sponsorPhase 1/Phase 2Sep 1, 2011
- NCT01745731Lead sponsorPhase 2Mar 31, 2011
- NCT01408381Lead sponsorPhase 2Jan 31, 2011
- NCT01454323Lead sponsorPhase 2Dec 31, 2010
- NCT01257776Lead sponsorPhase 1/Phase 2Dec 1, 2010
Details
- Founded
- Sevilla, ES Jan 1, 2008
- Last known activity
- May 1, 2016